http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106344583-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate | 2016-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf |
| publicationDate | 2017-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106344583-A |
| titleOfInvention | Application of Friedolanostanes in preparing drugs for treating acute gout |
| abstract | The invention provides application of Friedolanostanes in preparing drugs for treating acute gout. The experimental study result shows that Friedolanostanes has protective effect for acute gout model of vascular endothelial cell damage caused by urate, and can inhibit ICAM-1 expression. The application of Friedolanostanes in preparing drugs for treating acute gout is disclosed for the first time, and the preventive activity for acute gout is strong; the application has outstanding substantive features; meanwhile, the Friedolanostanes applied to prevent and treat acute gout has significant progress obviously. |
| priorityDate | 2016-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.